Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen. 1996

O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
July 1994, Bone marrow transplantation,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
December 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
July 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
June 1995, Sangre,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
July 1998, Bone marrow transplantation,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
November 1996, Journal of pediatric hematology/oncology,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
May 1996, Bone marrow transplantation,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
December 1993, British journal of haematology,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
January 2021, Annals of hematology,
O Arslan, and H Akan, and H Koç, and M Beksaç, and O Ilhan, and M Ozcan, and S Yalçín, and G Gürman, and N Konuk, and A Uysal
July 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!